Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

GENERALLY, A CHRONIC illness is a medical condition that lasts for six months or longer, usually requires ongoing care and treatment, and may limit your daily activities, says Sumanth Prabhu, M.D., ...

Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

HC Wainwright reissued their buy rating on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a report released on ...

One woman has shared how she started getting violent allergic reactions when eating certain foods. Lisa O'Brien said she started getting a red rosacea-like rash across her face which followed shortly ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Two ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing sufferers thousands of dollars in medical expenses.

Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in weight loss.

In a challenging market environment, PALI Pharmaceuticals' stock has tumbled to a 52-week low, with shares dropping to a price level of 1.15 USD. According to InvestingPro data, the company maintains ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...